Hims & Hers Health Taps Amazon Executive as Operating Chief

Dow Jones

2025/05/05

By Denny Jacob

Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer.

The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company looks to expand access to its portfolio--which includes treatments for sexual health and weight loss, among other areas.

Kabbani spent nearly 20 years at the e-commerce retailer and led Amazon's acquisition of PillPack and its pharmacy business, according to Hims.

The San Francisco company in April said that COO Melissa Baird would transition into an advisory role in the coming months. A departure date hadn't been determined, Hims said at the time. The company had also said it would enter a long-term agreement with Baird, who joined in 2018, to lean on her time and experience.

Hims' appointment comes as the landscape for weight-loss drugs is changing. The company in February said it would stop offering compounded semaglutide, a version of the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. Novo Nordisk at the time said the Food and Drug Administration determined that the shortage of Wegovy and Ozempic has been resolved, while fellow drugmaker Eli Lilly cut prices of weight-loss drug Zepbound.

Hims and Novo Nordisk in April announced they would collaborate on a weight-loss treatment offering, including access to Wegovy and other services.

Hims is scheduled to report first-quarter results after Monday's closing bell.

Write to Denny Jacob at denny.jacob@wsj.com

(END) Dow Jones Newswires

May 05, 2025 09:29 ET (13:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533758240"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533758240\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533758240?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-05 21:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533758240","market":"us","top_or_hot":-1,"title":"Hims & Hers Health Taps Amazon Executive as Operating Chief","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  Hims &amp; Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. \n</p>\n<p>\n  The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company looks to expand access to its portfolio--which includes treatments for sexual health and weight loss, among other areas. \n</p>\n<p>\n  Kabbani spent nearly 20 years at the e-commerce retailer and led Amazon's acquisition of PillPack and its pharmacy business, according to Hims. \n</p>\n<p>\n  The San Francisco company in April said that COO Melissa Baird would transition into an advisory role in the coming months. A departure date hadn't been determined, Hims said at the time. The company had also said it would enter a long-term agreement with Baird, who joined in 2018, to lean on her time and experience. \n</p>\n<p>\n  Hims' appointment comes as the landscape for weight-loss drugs is changing. The company in February said it would stop offering compounded semaglutide, a version of the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. Novo Nordisk at the time said the Food and Drug Administration determined that the shortage of Wegovy and Ozempic has been resolved, while fellow drugmaker Eli Lilly cut prices of weight-loss drug Zepbound. \n</p>\n<p>\n  Hims and Novo Nordisk in April announced they would collaborate on a weight-loss treatment offering, including access to Wegovy and other services. \n</p>\n<p>\n  Hims is scheduled to report first-quarter results after Monday's closing bell. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2025 09:29 ET (13:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health Taps Amazon Executive as Operating Chief</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health Taps Amazon Executive as Operating Chief\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-05 21:29</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Denny Jacob \n</p>\n<pre>\n \n</pre>\n<p>\n  Hims &amp; Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. \n</p>\n<p>\n  The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company looks to expand access to its portfolio--which includes treatments for sexual health and weight loss, among other areas. \n</p>\n<p>\n  Kabbani spent nearly 20 years at the e-commerce retailer and led Amazon's acquisition of PillPack and its pharmacy business, according to Hims. \n</p>\n<p>\n  The San Francisco company in April said that COO Melissa Baird would transition into an advisory role in the coming months. A departure date hadn't been determined, Hims said at the time. The company had also said it would enter a long-term agreement with Baird, who joined in 2018, to lean on her time and experience. \n</p>\n<p>\n  Hims' appointment comes as the landscape for weight-loss drugs is changing. The company in February said it would stop offering compounded semaglutide, a version of the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. Novo Nordisk at the time said the Food and Drug Administration determined that the shortage of Wegovy and Ozempic has been resolved, while fellow drugmaker Eli Lilly cut prices of weight-loss drug Zepbound. \n</p>\n<p>\n  Hims and Novo Nordisk in April announced they would collaborate on a weight-loss treatment offering, including access to Wegovy and other services. \n</p>\n<p>\n  Hims is scheduled to report first-quarter results after Monday's closing bell. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Denny Jacob at denny.jacob@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 05, 2025 09:29 ET (13:29 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HIMS","symbol_name":"Hims & Hers Health Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2533758240","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533758240","pubTimestamp":1746451740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer.The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company looks to expand access to its portfolio--which includes treatments for sexual health and weight loss, among other areas.Kabbani spent nearly 20 years at the e-commerce retailer and led Amazon's acquisition of PillPack and its pharmacy business, according to Hims.The San Francisco company in April said that COO Melissa Baird would transition into an advisory role in the coming months. A departure date hadn't been determined, Hims said at the time. The company had also said it would enter a long-term agreement with Baird, who joined in 2018, to lean on her time and experience.Hims' appointment comes as the landscape for weight-loss drugs is changing. The company in February said it would stop offering compounded semaglutide, a version of the active ingredient in weight-loss drugs Wegovy and Ozem","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"HIMS":"Hims & Hers Health Inc."},"translate_title":"Hims&Hers Health任命亚马逊高管为首席运营官","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HIMS":0.9},"content_text":"By Denny Jacob \n\n\n \n\n\n  Hims & Hers Health appoints former Amazon executive Nader Kabbani as its chief operating officer. \n\n\n  The telehealth-consultation platform on Monday said Kabbani will oversee operations as the company looks to expand access to its portfolio--which includes treatments for sexual health and weight loss, among other areas. \n\n\n  Kabbani spent nearly 20 years at the e-commerce retailer and led Amazon's acquisition of PillPack and its pharmacy business, according to Hims. \n\n\n  The San Francisco company in April said that COO Melissa Baird would transition into an advisory role in the coming months. A departure date hadn't been determined, Hims said at the time. The company had also said it would enter a long-term agreement with Baird, who joined in 2018, to lean on her time and experience. \n\n\n  Hims' appointment comes as the landscape for weight-loss drugs is changing. The company in February said it would stop offering compounded semaglutide, a version of the active ingredient in weight-loss drugs Wegovy and Ozempic, after the first quarter. Novo Nordisk at the time said the Food and Drug Administration determined that the shortage of Wegovy and Ozempic has been resolved, while fellow drugmaker Eli Lilly cut prices of weight-loss drug Zepbound. \n\n\n  Hims and Novo Nordisk in April announced they would collaborate on a weight-loss treatment offering, including access to Wegovy and other services. \n\n\n  Hims is scheduled to report first-quarter results after Monday's closing bell. \n\n\n \n\n\n  Write to Denny Jacob at denny.jacob@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 05, 2025 09:29 ET (13:29 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}